Search and Filter
Results per Page:
Playing hide-and-seek with DTCs: new CAR-T therapy reduces risk of recurrent breast cancer
From the Ghajar Lab, Human Biology and Public Health Sciences Divisions, and the Riddell Lab, Translational Science and Therapeutics Division
New initiative bolsters Washington state life sciences
Fred Hutch researchers awarded over $4M in grants from the Washington Research Foundation
Location, location, location: where is key for CAR T-cell therapy
From the Walter lab, Translational Science and Therapeutics Division
Why do our immune systems wane with age? Impaired thymus archiTECture might be one culprit.
From The Dudakov Lab, Translational Science and Therapeutics Division
Understanding how microbial imbalances may influence Juvenile Dermatomyositis, a rare immune-mediated disease
From the Dey Lab, Pathogen Associated Malignancies Program of the Cancer Consortium
Fred Hutch launches Atlas of Inspiring Hispanic/Latinx Scientists
Online atlas recognizes contributions of Hispanic and Latinx scientists
‘Black hole’ formed by aging cells hobbles key immune organ’s function, regeneration
Collaborative project reveals non-functional cells that accumulate in aging thymus
A foamy way to improve cost, efficiency and safety of gene therapy
From the Stephan Lab, Translational Science and Therapeutics Division
$5.25M from the Kuni Foundation propels innovative adult oncology research
Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies
Safety and feasibility approved for new therapy to treat relapsed hematologic malignancies
From the Bleakley Lab, Translational Science & Therapeutics Division
Cost-effective device trains immune cells to kill tumor cells
From the Matthias Stephan Lab, Translational Science & Therapeutics Division
Fred Hutch announces eight recipients of 2024 Dr. Eddie Méndez Scholar Award
National award recognizes exceptional postdoctoral researchers from historically underrepresented groups in science
Secret to tamping down GVHD may lie in microbial genetics
Preclinical bone marrow transplant study shows donor immune cells that target recipient microbiome can influence GVHD severity
Taking a frothy risk to advance gene therapy
Fred Hutch scientists hope foam could be a cost-reducing, access-enhancing vehicle for delivering future gene therapies
Could a medicated foam make gene therapies more accessible?
In Nature Communications, Fred Hutch bioengineer Matthias Stephan, MD, PhD, reports latest effort to use innovative materials to improve immune-based therapies.
500 replication origins in the yeast genome? Try 5000!
From the Bedalov Lab, Translational Science and Therapeutics and Human Biology Divisions
La densa matriz extracelular tumoral impide la infiltración de la inmunoterapia
De los laboratorios Warren y Tykodi, División de Ciencia Traslacional y Terapéutica
HLA haplotype allelic variations can influence leukemia recurrence after blood stem cell transplantation
From the Petersdorf Group, Translational Science and Therapeutics Division